Home News Latest News HPRA Drug Safety Newsletter Edition 90

HPRA Drug Safety Newsletter Edition 90

Home News Latest News HPRA Drug Safety Newsletter Edition 90
November 05, 2018

​The 90th edition of the HPRA drug safety newsletter. 

The 90th edition of the HPRA drug safety newsletter includes information on the following medicines:

  • Rivaroxaban (Xarelto) – Increase in all-cause mortality, thromboembolic and bleeding events in patients after transcatheter aortic valve replacement in a prematurely stopped clinical trial.
  • Insulin-containing products -0 Risks of medication errors associated with extraction of insulin from pre-filled pens and cartridges for reusable pens.
  • Hydrochlorothiazide (HCTZ) – Risk of non-melanoma skin cancer (NMSC)
  • Dolutegravir – Neural tube defects reported in infants.

Subscribe to our eZine

Receive our monthly newsletter with news and other content relevant to the Irish nursing and midwifery professions.